The effect of teltonal on sore throat after tracheal intubation in general anesthesia

The effect single dose of Harppagophytum capsule (teltonal) on sore throat after tracheal intubation in general anesthesia.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014031216956N1

Enrollment

Registered

2015-06-22

Start date

2015-05-18

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sore throat after tracheal intubation.

Interventions

Intervention 1: One hour before intubation will be given a teltonal cap (480mg)to Intervention group with 50cc water. Intervention 2: one hour before intubation empty capsule with 50cc water will be

Prevention

Placebo

One hour before intubation will be given a teltonal cap (480mg)to Intervention group with 50cc water.

one hour before intubation empty capsule with 50cc water will be given to control group as placebo.

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all 20_60 years old patient candidated for general surgery; ASA class I_II. Exclusion criteria: use NSAIDs in two weak before surgery; the history of sore throat and upper respiratory tract infections; difficult intubation; long time surgery over than 3 hours; drug reaction; addiction; psychopathic conditions and inappropriate position.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sore throat. Timepoint: , 2, 6 and 24 hours after operation. Method of measurement: visual analog scale.	—

Secondary

Measure	Time frame
Headache. Timepoint: daily. Method of measurement: graded questionnaire.;Anorexia. Timepoint: daily. Method of measurement: graded questionnaire.;Nausea and vomiting. Timepoint: daily. Method of measurement: graded questionnaire.;Diarrhea. Timepoint: daily. Method of measurement: graded questionnaire.;Tinnitus. Timepoint: daily. Method of measurement: graded questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Mohammadipour Anvari

Tabriz University of Medical Sciences

dr.anvari22@yahoo.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026